🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
This expanded access program will provide an investigational treatment opti...
Status
No Longer Available
Location
Alabama Center for Childhood Cancer And Blood Disorders, Children's of Alabama
Start Date
TBD
Trial ID
NCT05918913
Treatments Being Tested
This research is being conducted to determine a safe and effective dose of ...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2024-12-06
Trial ID
NCT06313437
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of re...
Status
Completed
Location
University of California, San Francisco (UCSF) Benioff Children's Hospital
Start Date
2022-03-09
Trial ID
NCT05326516
Treatments Being Tested
This phase I trial tests the safety, side effects, best dose and effectiven...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-12-06
Trial ID
NCT06575296
To learn about the safety and effects of revumenib in combination with blin...
Status
Not Yet Recruiting
Location
MD Anderson Cancer
Start Date
2026-11-18
Trial ID
NCT07283640
Treatments Being Tested
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
The objective of this observational study is to evaluate the efficacy and s...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-11-01
Trial ID
NCT07559695
This phase Ib trial tests the safety, side effects, and best dose of SNDX-5...
Status
Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Start Date
2024-06-20
Trial ID
NCT05886049
This phase II trial tests how well adding revumenib to usual treatment (bli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-14
Trial ID
NCT07636564
Treatments Being Tested